Element announces the presentation of successful results of the Jewel® IDE study in a featured science presentation at the American Heart Association’s 2023 Annual Scientific Sessions

Pliant announces the presentation of preclinical data and clinical data from the INTEGRIS-PSC Phase 2a trial of bexotegrast in patients with primary sclerosing cholangitis. These posters were presented at The Liver Meeting^®.

Tango Therapeutics to highlight preclinical data on PRMT5 inhibitors at the society for neuro-oncology (SNO) 28^th annual meeting.

CARGO Therapeutics Announces Pricing of Initial Public Offering

Terremoto Biosciences Closes $175 Million Series B Financing